Skip to main content
Top

Current Hypertension Reports

Issue 6/2007

Content (18 Articles)

Invited Commentary

Blood pressure and renal damage

Albert Mimran

Invited Commentary

Blood pressure control and stroke mortality across populations

Josep Redon, Luis Cea-Calvo

Clinical Trials Report

Battling the four horsemen of the metabolic syndrome

Thomas R. Lux, Heinrich Taegtmeyer

Clinical Trials Report

Vitamin D levels and the risk of hypertension

Steven A. Atlas, Sandeep S. Patel

Sarcolemmal fatty acid transport in normal and diseased hearts

Jan F. C. Glatz, Arend Bonen, Joost J. F. P. Luiken

Diabetic cardiomyopathy

Ankur A. Karnik, Anjali V. Fields, Richard P. Shannon

Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia

Babbette D. LaMarca, Michael J. Ryan, Jeffrey S. Gilbert, Sydney R. Murphy, Joey P. Granger

Management of arterial hypertension in obese patients

Ulrich O. Wenzel, Christian Krebs

Management of hypertension in patients with left ventricular hypertrophy

Cesare Cuspidi, Carla Sala, Alberto Zanchetti

Adrenal steroids and the metabolic syndrome

Stephen P. Thomson, Craig S. Stump, L. Romayne Kurukulasuriya, James R. Sowers

Stress reduction programs in patients with elevated blood pressure: A systematic review and meta-analysis

Maxwell V. Rainforth, Robert H. Schneider, Sanford I. Nidich, Carolyn Gaylord-King, John W. Salerno, James W. Anderson

Obstructive sleep apnea and hypertension: Mechanisms, evaluation, and management

John M. Dopp, Kevin J. Reichmuth, Barbara J. Morgan

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine